Literature DB >> 11672946

The relationship between cannabis use and other substance use in the general population.

L Degenhardt1, W Hall, M Lynskey.   

Abstract

This study examined if (1) there is an association in the general population between cannabis use, DSM-IV abuse and dependence, and other substance use and DSM-IV substance abuse/dependence; (2) if so, is it explained by demographic characteristics or levels of neuroticism? It used data from the Australian National Survey of Mental Health and Well-Being (NSMHWB), a stratified, multistage probability sample of 10,641 adults, representative of the general population. DSM-IV diagnoses of substance abuse and dependence were derived using the Composite International Diagnostic Interview (CIDI). There was a strong bivariate association between involvement with cannabis use in the past 12 months and other substance use, abuse and dependence. In particular, cannabis abuse and dependence were highly associated with increased risks of other substance dependence. These associations remained after including other variables in multiple regression. Cannabis use without disorder was strongly related to other drug use, an association that was not explained by other variables considered here. The high likelihood of other substance use and substance use disorders needs to be considered among persons seeking treatment for cannabis use problems.

Entities:  

Mesh:

Year:  2001        PMID: 11672946     DOI: 10.1016/s0376-8716(01)00130-2

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  54 in total

1.  Relationships between drinking motives and smoking expectancies among daily smokers who are also problem drinkers.

Authors:  Dawn W Foster; Michael J Zvolensky; Lorra Garey; Joseph W Ditre; Norman B Schmidt
Journal:  J Dual Diagn       Date:  2014

2.  Identifying subtypes of dual alcohol and marijuana users: a methodological approach using cluster analysis.

Authors:  Magdalena Harrington; Janette Baird; Christina Lee; Ted Nirenberg; Richard Longabaugh; Michael J Mello; Robert Woolard
Journal:  Addict Behav       Date:  2011-07-22       Impact factor: 3.913

3.  Marijuana use disorder symptoms among recent onset marijuana users.

Authors:  Lisa Dierker; William Mendoza; Renee Goodwin; Arielle Selya; Jennifer Rose
Journal:  Addict Behav       Date:  2017-01-06       Impact factor: 3.913

4.  Comorbidity and temporal relations of alcohol and cannabis use disorders from youth through adulthood.

Authors:  Susan C Duncan; Jeff M Gau; Richard F Farmer; John R Seeley; Derek B Kosty; Peter M Lewinsohn
Journal:  Drug Alcohol Depend       Date:  2015-01-28       Impact factor: 4.492

5.  Marijuana use from adolescence to adulthood: developmental trajectories and their outcomes.

Authors:  Judith S Brook; Chenshu Zhang; Carl G Leukefeld; David W Brook
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2016-05-11       Impact factor: 4.328

Review 6.  Cannabis Smoking in 2015: A Concern for Lung Health?

Authors:  Jason R Biehl; Ellen L Burnham
Journal:  Chest       Date:  2015-09       Impact factor: 9.410

7.  Gender differences in the associations among marijuana use, cigarette use, and symptoms of depression during adolescence and young adulthood.

Authors:  Natania A Crane; Scott A Langenecker; Robin J Mermelstein
Journal:  Addict Behav       Date:  2015-05-24       Impact factor: 3.913

Review 8.  Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal.

Authors:  J L Scavone; R C Sterling; E J Van Bockstaele
Journal:  Neuroscience       Date:  2013-04-24       Impact factor: 3.590

Review 9.  A review of epidemiologic research on smoking behavior among persons with alcohol and illicit substance use disorders.

Authors:  Andrea H Weinberger; Allison P Funk; Renee D Goodwin
Journal:  Prev Med       Date:  2016-05-16       Impact factor: 4.018

Review 10.  Role of endocannabinoid system in mental diseases.

Authors:  Jorge Manzanares; Leyre Urigüen; Gabriel Rubio; Tomás Palomo
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.